Genetically Modified T Cells and Decitabine in Treating Patients With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Roswell Park Cancer Institute
Roswell Park Cancer Institute
National Institutes of Health Clinical Center (CC)
Immatics US, Inc.
Roswell Park Cancer Institute
PACT Pharma, Inc.
Herlev Hospital
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)
Cancer Research UK